Virtual Patient Cohorts to Illuminate Immunologic Drivers of Influenza Severity
Virtual Patient Cohorts to Illuminate Immunologic Drivers of Influenza Severity
批准号:
10628017
负责人:
Morgan Craig
金额:
$60.14万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-01 至 2027-05-31
关键词:
AddressAffectAfrican AmericanAgeAnimalsAutomobile DrivingBiologicalBiological FactorsBiological MarkersCD8B1 geneCOVID-19CalibrationCellsCessation of lifeClinicalComputer ModelsComputing MethodologiesCorrelation StudiesCytomegalovirusDataDiseaseDisease ManagementDisease OutcomeDisease ProgressionDoseEconomic BurdenEnvironmental Risk FactorFutureGeneticGoalsHealthHeritabilityHeterogeneityHumanImmuneImmune responseImmunityImmunological ModelsImmunologicsImmunologyIndividualInfectionInflammationInflammatoryInfluenzaInfluenza vaccinationInfrastructureIntegration Host FactorsInterleukin-6KnowledgeLungMacrophageMathematicsMethodsModelingMorbidity - disease rateMusNatural ImmunityOutcomeParainfluenza Virus InfectionsPathogenicityPatient-Focused OutcomesPatternPopulationProcessPublic HealthPulmonary PathologyResearchRespiratory Tract InfectionsSeasonsSerologySeveritiesSeverity of illnessSourceSouth AmericanT-LymphocyteVaccinationValidationVariantViralVirusVitamin A DeficiencyWorkclinical examinationcohortcomorbiditycoronavirus diseasecytokinedigital twinexperimental studyhuman dataimmunopathologyimprovedin silicoin vivoinfluenza infectioninfluenzavirusmonocytemortalitymouse modelneutrophilpathogenpredictive markerpredictive modelingrespiratory virusresponserisk predictionseasonal influenzasexsuccesstime usetoolvirtual patient
中文摘要
项目摘要
流感病毒每年导致大量的疾病和死亡,突出了其健康和
经济负担。这种疾病的管理是困难的,而且很少有人知道不同的宿主因素
导致异质性结果。为了推进理解不同免疫反应的目标,
流感和预测风险,至关重要的是开发新的工具,可以定义个性化的免疫轨迹,
同时解释异质性的多种来源,并准确预测驱动疾病的动力学
进展该项目旨在解决在确定宿主因素对疾病结果的影响方面存在的差距,
在开发准确预测炎症的呼吸道感染计算方法方面存在差距,
疾病严重程度。这些研究将开发和利用新的预测性系统免疫模型,
使用虚拟患者队列的人群旨在区分临床结果并识别下游
不同水平的基础免疫力。
英文摘要
Project Summary
Influenza viruses result in a significant number of illnesses and deaths each year highlighting its health and
economic burden. Management of this disease is difficult, and little is known about how different host factor
contribute to heterogenous outcomes. To advance the goals of understanding the diverse immune responses to
influenza and predict risk, it is essential to develop new tools that can define individualized immune trajectories,
simultaneously account for multiple sources of heterogeneity, and accurately predict dynamics that drive disease
progression. This project addresses gaps in identifying the impact that host factors have disease outcome and
gaps in developing computational methods for respiratory infections that accurately predict inflammation and
disease severity. The studies will develop and exploit new predictive systemic immune models and simulate
human populations using virtual patient cohorts aims at differentiating clinical outcomes and identify downstream
effects of varying levels of basal immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金